AstraZeneca’s Covid Vaccine May Have Posed a Higher Heart Risk for Young Women, Study Shows

A new analysis examined deaths in Britain, where the company’s product was restricted in 2021 because of safety concerns.

View original article
Contributor: Apoorva Mandavilli